The complete amino acid sequence of bovine antithrombin (ATIII). 1991

H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
Laboratoire de Biochimie, Centre National de la Recherche Scientifique, Strasbourg, France.

Bovine antithrombin (ATIII) is a glycoprotein of Mr 56,600. Its primary structure was established using peptide sequences from five different digests. Bovine ATIII exhibits four glcosylation sites as well as human ATIII. The primary structures of bovine and human ATIII were compared: all the residues required for the integrity of the heparin-binding domain are strictly conserved. However, there are differences in the secondary structures of both proteins, bovine and human ATIII.

UI MeSH Term Description Entries
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D003488 Cyanogen Bromide Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes. Bromide, Cyanogen
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
July 1971, Biochemical and biophysical research communications,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
April 1977, FEBS letters,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
September 1970, The Journal of biological chemistry,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
December 1988, FEBS letters,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
November 1974, The Journal of biological chemistry,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
December 1980, Biochemical and biophysical research communications,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
January 1986, The Italian journal of biochemistry,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
March 1982, The Journal of biological chemistry,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
January 1974, International journal of peptide and protein research,
H Mejdoub, and M Le Ret, and Y Boulanger, and M Maman, and J Choay, and J Reinbolt
October 1975, The Journal of biological chemistry,
Copied contents to your clipboard!